Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2003
08/21/2003US20030157196 Compositions and methods for creating an air release mechanism to maintain skin health
08/21/2003US20030157187 Compositions and methods for treating or preventing inflammatory diseases
08/21/2003US20030157184 Preparation of powder agglomerates
08/21/2003US20030157183 Method for encapsulating fine solid particles in the form of microcapsules
08/21/2003US20030157181 Nanocapsules having a polyelectrolyte envelope
08/21/2003US20030157179 Use of magnetic particles
08/21/2003US20030157178 Injectable depot composition
08/21/2003US20030157177 In combination with a matrix vehicle selected from glycerol esters, hydrogenated oils, esterified polyethylene glycols, waxes and their mixtures
08/21/2003US20030157173 Timed, sustained release systems for propranolol
08/21/2003US20030157172 Pharmaceutical suspension for oral administration
08/21/2003US20030157171 Chitosan-xanthane hydrogel including in its matrix a poorly water soluble drug which upon swelling of hydrogel in aqueous medium becomes at least partially solubilized and releasable therefrom
08/21/2003US20030157170 Micellar drug delivery vehicles and precursors thereto and uses thereof
08/21/2003US20030157163 Semipermeable walled container housing capsule comprising progestin and estrogen for sustained-release via osmotic pressure changes within
08/21/2003US20030157161 Such as paclitaxel dispersed in micelle or liposome
08/21/2003US20030157158 Enhanced liposomal thioretinaco ozonide compositions and liposomal carrier
08/21/2003US20030157157 Such as progestins and estrogens; comprises sodium hydroxide as release agent; hormone replacement therapy; female contraception
08/21/2003US20030157156 Such as sodium hydroxide; sustained release; side effect reduction; urogenital disorders
08/21/2003US20030157155 Compositions for use as penetration promoters in transdermal formulations for highly lipophilic active ingredients
08/21/2003US20030157146 Mixing with lactitol to synergistically increase immunoglobulin concentration in gut; side effect reduction
08/21/2003US20030157142 Implants with a phosphazene-containing coating
08/21/2003US20030157140 Parenteral preparation having structure of basement polymer layer, carrying layer containing objective substances selected from drugs, aroma chemicals, antigens; carrying layer sandwiched between basement and surface layers
08/21/2003US20030157138 Pharmaceutical or cosmetic carrier or composition for topical application onto skin and/or mucosal membranes; treatment of skin diseases or disorders including eczema, psoriasis and dermatitis
08/21/2003US20030157115 Carrier with a dendrimeric poly-Lysine enabling multiple epitopes to be covalently attached thereto, a peptide with t epitope(s) and a carbohydrate with a b epitope that is not a sialoside; immunotherapy
08/21/2003US20030157093 Immunotoxin with in vivo t cell suppressant activity and methods of use
08/21/2003US20030157092 Anticancer agents; removal bone marrow, contactor with protein; reinsertion
08/21/2003US20030157091 Computer analyzing; binding to polypeptide
08/21/2003US20030157088 Mixture of enzyme and enzyme inhibitors
08/21/2003US20030157085 Antitumor agents
08/21/2003US20030157056 Modified cytokines for use in cancer therapy
08/21/2003US20030157055 Modified cytokines for use in cancer therapy
08/21/2003US20030157052 Prodrug for in situ regeneration; water solubility
08/21/2003US20030157036 Topical dapsone for the treatment of acne
08/21/2003US20030157032 Antihistamines, bronchodilator agents, antiinflammatory agents; mixture of drug and propellant
08/21/2003US20030157030 Methods and compositions for therapeutic use of rna interference
08/21/2003US20030157029 Methods of administering and enhancing absorption of pharmaceutical agents
08/21/2003CA2752553A1 Anti-cd20 antibodies and fusion proteins thereof and methods of use
08/21/2003CA2516331A1 Combination therapy using glycosaminoglycans and therapeutic agents for the treatment of respiratory disorders
08/21/2003CA2476468A1 Protein carrier system for therapeutic oligonucleotides
08/21/2003CA2476131A1 Composition for skin healing comprising a chitosan hydrogel
08/21/2003CA2476120A1 Methods and compositions for the treatment of eye diseases
08/21/2003CA2475928A1 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds
08/21/2003CA2475722A1 Formulations of atorvastatin stabilized with alkali metal additions
08/21/2003CA2475659A1 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
08/21/2003CA2475592A1 Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
08/21/2003CA2475544A1 Oral dosage form for controlled drug release
08/21/2003CA2475522A1 Method of radio-labelling biomolecules
08/21/2003CA2475388A1 Chimeric molecules for cleavage in a treated host
08/21/2003CA2475338A1 Treatment of ophthalmic disorders using urea and urea derivatives
08/21/2003CA2475102A1 Stabilized synthetic immunogen delivery systems
08/21/2003CA2474943A1 Sugar stabilized antibody-containing solution formulations
08/21/2003CA2474782A1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
08/21/2003CA2474626A1 Carboxylic acid compounds for use as surfactants
08/21/2003CA2473569A1 Tablets having improved tabletting characteristics and process for producing the same
08/21/2003CA2472956A1 Formulation strategies in stabilizing peptides in organic solvents and in dried states
08/21/2003CA2472744A1 Oral solid solution formulation of a poorly water-soluble active substance
08/21/2003CA2372816A1 Aspirin containing composition for topical use and method of treatment
08/20/2003EP1336410A1 Protein injection preparations
08/20/2003EP1336408A1 Water-soluble liquid internal medicine
08/20/2003EP1336405A1 Formulations of atorvastatin stabilized with alkali metal additions
08/20/2003EP1336341A2 Water dispersible compositions containing natural hydrophilic, water-insoluble pigments, methods of preparing same and their use
08/20/2003EP1335953A2 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use
08/20/2003EP1335938A2 Apolipoprotein analogues
08/20/2003EP1335937A2 Mixed fibrils
08/20/2003EP1335921A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy
08/20/2003EP1335748A1 Antibiotic adducts with natural polysaccharide polymers in the form of aqueous solutions
08/20/2003EP1335747A1 A composition of sodium channel blocking compound
08/20/2003EP1335729A2 Inhalative solution formulation containing a tiotropium salt
08/20/2003EP1335728A1 Novel medicament compositions based on tiotropium salts and on salmeterol salts
08/20/2003EP1335726A1 Modified prodrug forms of ap/amp
08/20/2003EP1335710A2 Soft capsules comprising a starch mixture having a reduced branching degree
08/20/2003EP1335709A2 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole
08/20/2003EP1335707A2 Novel formulations of carvedilol
08/20/2003EP1335706A2 Microspheres of pancreatic enzymes with high stability
08/20/2003EP1335705A2 Preparation of drug particles using evaporation precipitation into aqueous solutions
08/20/2003EP1335704A2 Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
08/20/2003EP1335693A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
08/20/2003EP1335689A1 Loratadine transdermal device and methods
08/20/2003EP1255576B1 Mineral-polymer hybrid composition
08/20/2003EP1239836B1 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
08/20/2003EP1143968B1 Composition and methods for administration of water-insoluble paclitaxel derivatives
08/20/2003EP1135147B1 Method for producing medicaments from plant extracts, in a solid form of administration
08/20/2003EP1135110B1 Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses
08/20/2003EP1128819B1 New controlled release bead, a method of producing the same and multiple unit formulation comprising it
08/20/2003EP0998304B1 Pharmaceutical compositions comprising a basic drug, a cyclodextrin, a polymer and an acid
08/20/2003EP0966295B1 Calcareous material
08/20/2003EP0934058B1 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
08/20/2003EP0876109B1 Water dispersible compositions containing natural hydrophobic pigment, method of preparing same and their use
08/20/2003EP0865288B1 Bioartificial devices and cellular matrices therefor
08/20/2003EP0861091B1 Immunotoxin containing a disulfide-stabilized antibody fragment
08/20/2003EP0850408B1 Method of measuring nitric oxide
08/20/2003EP0679401B1 Composition for curing lesioned tissue, process for producing the same, and use thereof
08/20/2003CN1437611A 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives
08/20/2003CN1437580A 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
08/20/2003CN1437486A Stabiliser for radiopharmaceuticals
08/20/2003CN1437483A Oral preparations for diabetes
08/20/2003CN1437472A Highly concentrated stable meloxicam solutions
08/20/2003CN1437466A Methods for pulmonary delivery of interleukin-2
08/20/2003CN1437465A Use of an acetylated pre-gelled starch with a high content of amylose
08/20/2003CN1437464A Improved water-insoluble drug particle process
08/20/2003CN1437463A System and method for treating a mucosal surface
1 ... 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 ... 1712